The University of Rochester received a $812,602 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMAGING CANCER MICROENVIRONMENT HOT SPOTS INVOLVED IN PROGRESSION OF MYELODYSPLASTIC SYNDROMES." The research, which will take place from May 2024 to May 2027, aims to improve understanding of the cancer microenvironment and its role in the progression of myelodysplastic syndromes, a group of disorders where the bone marrow fails to produce enough healthy blood cells. The federal grant will enable the University of Rochester to leverage its expertise in areas such as medicine, optics, and data science to advance scientific knowledge and potentially develop new diagnostic or treatment approaches for this condition, which is of particular relevance to military personnel and veterans.
Generated 1/28/25, 7:43 AM